OncoHost is a technology company transforming the approach to precision medicine for improved patient outcomes. The company aims to understand the patient's unique response to therapy to overcome one of the major obstacles in clinical oncology today – resistance to treatment. OncoHost developed the PROphet platform. Combining bioinformatics, system biology, proteomic pattern recognition and machine learning, PROphet provides clinicians with actionable clinical insights, optimal choice of therapy, and a better understanding of their patients' personalized cancer dynamics.